CS251792B2 - Method of compouns preparation with n-demethylmorphinane skeleton - Google Patents
Method of compouns preparation with n-demethylmorphinane skeleton Download PDFInfo
- Publication number
- CS251792B2 CS251792B2 CS855280A CS528085A CS251792B2 CS 251792 B2 CS251792 B2 CS 251792B2 CS 855280 A CS855280 A CS 855280A CS 528085 A CS528085 A CS 528085A CS 251792 B2 CS251792 B2 CS 251792B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- group
- hydrogen
- benzoyloxy
- acyloxy
- hydrogen atom
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 31
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 22
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims abstract description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 14
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 claims abstract description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- -1 alkali metal hydrogen carbonates Chemical class 0.000 claims abstract description 6
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims abstract description 6
- 230000007062 hydrolysis Effects 0.000 claims abstract description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 6
- 125000005843 halogen group Chemical group 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 238000002955 isolation Methods 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 3
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 3
- 239000002904 solvent Substances 0.000 claims abstract 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 238000010520 demethylation reaction Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical class C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 claims description 6
- 229930013930 alkaloid Natural products 0.000 claims description 4
- 229930013053 morphinan alkaloid Natural products 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 5
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 125000004185 ester group Chemical group 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 150000003797 alkaloid derivatives Chemical class 0.000 claims 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 150000008282 halocarbons Chemical class 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 235000015497 potassium bicarbonate Nutrition 0.000 claims 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims 1
- 239000011736 potassium bicarbonate Substances 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 235000011181 potassium carbonates Nutrition 0.000 claims 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 abstract description 3
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 abstract 1
- 150000008041 alkali metal carbonates Chemical class 0.000 abstract 1
- 150000003810 morphinanes Chemical class 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000001816 cooling Methods 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- 239000000908 ammonium hydroxide Substances 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 150000003512 tertiary amines Chemical class 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 150000003673 urethanes Chemical class 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 229960004126 codeine Drugs 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 4
- 150000003335 secondary amines Chemical class 0.000 description 4
- YYCRAERBSFHMPL-XFKAJCMBSA-N (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one Chemical compound O=C([C@@H]1O2)C=C[C@@]3(O)[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 YYCRAERBSFHMPL-XFKAJCMBSA-N 0.000 description 3
- YYCRAERBSFHMPL-UHFFFAOYSA-N 14beta-Hydroxycodeinone Natural products O1C2C(=O)C=CC3(O)C4CC5=CC=C(OC)C1=C5C23CCN4C YYCRAERBSFHMPL-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000012649 demethylating agent Substances 0.000 description 3
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 3
- 229910017053 inorganic salt Inorganic materials 0.000 description 3
- 229960005181 morphine Drugs 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IJVCSMSMFSCRME-KBQPJGBKSA-N Dihydromorphine Chemical compound O([C@H]1[C@H](CC[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O IJVCSMSMFSCRME-KBQPJGBKSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- OGDVEMNWJVYAJL-LEPYJNQMSA-N Ethyl morphine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OCC OGDVEMNWJVYAJL-LEPYJNQMSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- OGDVEMNWJVYAJL-UHFFFAOYSA-N Ethylmorphine Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OCC OGDVEMNWJVYAJL-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 2
- 150000001912 cyanamides Chemical class 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- RBOXVHNMENFORY-DNJOTXNNSA-N dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 description 2
- 229960000920 dihydrocodeine Drugs 0.000 description 2
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 description 2
- 229960004578 ethylmorphine Drugs 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 2
- 229960000240 hydrocodone Drugs 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- HVQUMOKQAJNIKK-ZTYRTETDSA-N (4r,4ar,7s,7ar,12bs)-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol Chemical compound C([C@@H](NCC1)[C@@H]2CC[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 HVQUMOKQAJNIKK-ZTYRTETDSA-N 0.000 description 1
- IKGNKASQBMZRJL-KOFBORESSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol Chemical compound O[C@H]([C@@H]1O2)CC[C@H]3[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4 IKGNKASQBMZRJL-KOFBORESSA-N 0.000 description 1
- QUSKGEMGNZXRRQ-UHFFFAOYSA-N 1,1,1-trichloro-2-(2,2,2-trichloroethoxy)ethane Chemical compound ClC(Cl)(Cl)COCC(Cl)(Cl)Cl QUSKGEMGNZXRRQ-UHFFFAOYSA-N 0.000 description 1
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- MFXFQKMUCYHPFQ-BKRJIHRRSA-N 6-monoacetylcodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](OC(C)=O)[C@@H]1OC1=C2C3=CC=C1OC MFXFQKMUCYHPFQ-BKRJIHRRSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- GXIWMALOYDSQMW-UHFFFAOYSA-N ClCl(=O)=O Chemical compound ClCl(=O)=O GXIWMALOYDSQMW-UHFFFAOYSA-N 0.000 description 1
- CNEQUQYUPUHQTD-VUICDJBSSA-N ClO.C1=CC(O)=C2C=3[C@@]45[C@@H](O2)C(=O)CC[C@H]4[C@@H](CC13)NCC5 Chemical compound ClO.C1=CC(O)=C2C=3[C@@]45[C@@H](O2)C(=O)CC[C@H]4[C@@H](CC13)NCC5 CNEQUQYUPUHQTD-VUICDJBSSA-N 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 101150014361 Delta gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- ONBWJWYUHXVEJS-ZTYRTETDSA-N Normorphine Chemical compound C([C@@H](NCC1)[C@@H]2C=C[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 ONBWJWYUHXVEJS-ZTYRTETDSA-N 0.000 description 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical class CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GMLSVPWCKDLNIC-SSTWWWIQSA-N [(4R,4aR,7S,7aR,12bS)-9-methoxy-1,2,3,4,4a,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate Chemical compound CC(=O)O[C@H]([C@@H]1O2)C=C[C@H]3[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4 GMLSVPWCKDLNIC-SSTWWWIQSA-N 0.000 description 1
- LGGDXXJAGWBUSL-BKRJIHRRSA-N acetyldihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](OC(C)=O)[C@@H]1OC1=C2C3=CC=C1OC LGGDXXJAGWBUSL-BKRJIHRRSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- FXVUMYSWCCMYGL-UHFFFAOYSA-N azane;carbonyl dichloride Chemical compound N.ClC(Cl)=O FXVUMYSWCCMYGL-UHFFFAOYSA-N 0.000 description 1
- KZOKOEQTKWBKOK-XHQKLZHNSA-N azidomorphine Chemical compound O([C@H]1[C@@H](CC[C@H]23)N=[N+]=[N-])C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O KZOKOEQTKWBKOK-XHQKLZHNSA-N 0.000 description 1
- RDJGWRFTDZZXSM-RNWLQCGYSA-N benzylmorphine Chemical compound O([C@@H]1[C@]23CCN([C@H](C4)[C@@H]3C=C[C@@H]1O)C)C1=C2C4=CC=C1OCC1=CC=CC=C1 RDJGWRFTDZZXSM-RNWLQCGYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- RONNRWUMUHMWOH-UHFFFAOYSA-N bromo cyanate Chemical compound BrOC#N RONNRWUMUHMWOH-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- WGXZDYPGLJYBJW-UHFFFAOYSA-N chloroform;propan-2-ol Chemical compound CC(C)O.ClC(Cl)Cl WGXZDYPGLJYBJW-UHFFFAOYSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- XYYVYLMBEZUESM-CMKMFDCUSA-N codeinone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=CC(=O)[C@@H]1OC1=C2C3=CC=C1OC XYYVYLMBEZUESM-CMKMFDCUSA-N 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- HNPDNOZNULJJDL-UHFFFAOYSA-N ethyl n-ethenylcarbamate Chemical class CCOC(=O)NC=C HNPDNOZNULJJDL-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 1
- 229960001410 hydromorphone Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- FQXXSQDCDRQNQE-UHFFFAOYSA-N markiertes Thebain Natural products COC1=CC=C2C(N(CC3)C)CC4=CC=C(OC)C5=C4C23C1O5 FQXXSQDCDRQNQE-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- HKOIXWVRNLGFOR-KOFBORESSA-N norcodeine Chemical compound O[C@H]([C@@H]1O2)C=C[C@H]3[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4 HKOIXWVRNLGFOR-KOFBORESSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical group O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- FQXXSQDCDRQNQE-VMDGZTHMSA-N thebaine Chemical compound C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(OC)C5=C4[C@@]21[C@H]3O5 FQXXSQDCDRQNQE-VMDGZTHMSA-N 0.000 description 1
- 229930003945 thebaine Natural products 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical group C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005945 von Braun degradation reaction Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Electrophonic Musical Instruments (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Stringed Musical Instruments (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Polyesters Or Polycarbonates (AREA)
- Materials For Photolithography (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Finger-Pressure Massage (AREA)
- Cephalosporin Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Vynniez te týká způtobu přípravy sloučenin obecného vzorce IIIThe present invention relates to a process for the preparation of compounds of formula III
/111/ t morfinanovým skeletem odstraněním metylové skupiny z moofinanových alkaloidů obecného vzorce I(111) t with a morphinan skeleton by removing the methyl group from the moofinane alkaloids of formula I
/I/ úhrada metylové skupiny na atom dusíku moofinanových alkaloidů jinou, alkylovou skupinou vedla k objevu moofinových antagonistů důležitých z farmakologického a z terapeutického hlediska a rovněž k oddělení agonistického a antagonistického působení: · Adv. in Biochem. Psychqpharm. Svazek 8: Oaacotic Annaggonits, Paven Press, Oew York, 1974; E.F.Hahn: Drugs of the Future 9/6/, 443, 1984.(I) The replacement of the methyl group on the nitrogen atom of the moofinan alkaloids with another, alkyl group has led to the discovery of moofin antagonists important from a pharmacological and therapeutic point of view, as well as the separation of agonist and antagonist action: Adv. in Biochem. Psychqpharm. Volume 8: Oacacotic Annaggonits, Paven Press, Oew York, 1974; E. F. Hahn: Drugs of the Future 9/6 /, 443, 1984.
251792 ’251792 ’
Jakkoliv se morfinanové alkaloidy /morfin, kodein, tebain/ mohou získat z přírodních /rostlinných/ zdrojů, je snahou většiny způsobu přípravy připravovat sekundární aminy ze shora uvedených N-metyl-terciárních aminů. /Sekundární amin se pak může zpracovávat na žádanou sloučeninu N-alkylací./ Je vhodné nahrazovat metylovou skupinu na atom dusíku snadněji hydrolyzovatelnou funkční skupinou.Although morphinan alkaloids (morphine, codeine, thebaine) can be obtained from natural (plant) sources, the aim of most of the process is to prepare secondary amines from the above-mentioned N-methyl-tertiary amines. (The secondary amine can then be processed to the desired compound by N-alkylation.) It is desirable to replace the methyl group on the nitrogen atom with a more easily hydrolyzable functional group.
Požadavky ná N-demetylační činidla jsou následující: N-demetylační činidlo má být levné, stálé, snadno připravitelné, má mít dostatečnou reaktivitu, má zajišťovat dobré výtěžky a nemá být toxické.The requirements for the N-demethylating agent are as follows: The N-demethylating agent should be inexpensive, stable, easy to prepare, have sufficient reactivity, provide good yields and not be toxic.
Bromkyan, dříve v široké míře používaný pro N-demetylaci morfinanového skeletu /Н.А. Hageman; Org. Reactions 7, 198, 1935/ byl postupně vytlačen estery chloriuravenčí kyseliny v několika posledních letech. Největším nedostatkem bromkyanu je, že je dost toxický, v důsledku jeho předchodného charakteru je vhodné připravovat ho čerstvě před použitím; někteří autoři také upozorňují na jeho explozivitu.Bromocyanate, formerly widely used for N-demethylation of morphinan skeleton /Н.А. Hageman; Org. Reactions 7, 198, 1935] has been progressively displaced by chlorofluoric acid esters over the past few years. The biggest drawback of cyanogen bromide is that it is quite toxic, because of its pre-emptive character it is advisable to prepare it freshly before use; some authors also draw attention to its explosiveness.
Kyselá /nebo alkalická/ hydrolýza kyanamidů vytvořených při reakci podle von Brauna může vést v některých případech к částečnému rozkladu /nebo transformaci/ molekuly /А.С. Currie, G.T.Newbold, F.S. Spring: J. Chem. Soc. 4 693, 1961, nebo se reakce zastaví ve fázi močoviny /K.W. Bentley, D.G. Hardy: J. Am. Chem. Soc. 89, 3 281, 1967/.Acidic (or alkaline) hydrolysis of the cyanamides formed in the von Braun reaction may, in some cases, lead to partial decomposition (or transformation) of the molecule. Currie, G. T. Newbold, F.S. Spring: J. Chem. Soc. No. 4,693, 1961, or the reaction is stopped in the urea phase / K.W. Bentley, D.G. Hardy, J. Am. Chem. Soc. 89, 3281 (1967)].
tNa rozdíl od toho se s estery chlormravenčí kyseliny snadněji pracuje, jsou méně toxické a jejich čištění je možné destilací. Již používané metylestery, etylestery a fenylestery poskytovaly od počátku vynikající výsledky /85 až 95% výtěžky/ při demetylaci atomu dusíku /М.М. Abdel-Monem, P.S. Portoghese: J.Med: Chem. 15, str. 208, 1972; G.A. Brine, K.G. Boldt, C.K. Hart, F.I. Carroll: Organic Prep. Proced. Int. 8^, str.j 103, 1976; K.C. Rice, E. L. May: J. Heterocyclic Chem. 14, 665, 1977/.In contrast, chloroformic acid esters are easier to work with, are less toxic and can be purified by distillation. The methyl esters, ethyl esters and phenyl esters already used gave excellent results (85-95% yields) from the demethylation of the nitrogen atom from the beginning. Abdel-Monem, P.S. Portoghese: J. Med: Chem. 15, 208 (1972); G.A. Brine, K.G. Boldt, C.K. Hart, F.I. Carroll: Organic Prep. Proced. Int. 8, p. 103, 1976; K.C. Rice, E.L. May: J. Heterocyclic Chem. 14, 665 (1977)].
Zjistilo se, že izolace derivátů urethanu jakožto meziproduktů není nutná, mohou se přímo dále převádět zásadou nebo hydrazinem. Jelikož jsou shora uvedené hydrolýzy spíše zdlouhavé /24 až 48 hodin/, přičemž v této době může již docházet к rozkladu а к vedlejším reakcím, byly pro N-demetylaci navrženy 2,2,2-trichloretylester chlormravenčí kyseliny /I.J. Browitz, V. Diakiw: J. Heterocyclic Chem. 12, str. 1 123, 1975/; J.I. DeGraw, J.H. Lawson, J.L. Crase, H.L. Jonson, M. Ellis, E.T. Uyeno, G.H. Loew, D.S. Berkowitz: J. Med. Chem. 21, str. 415, 1978/ a vinylester kyseliny chlormravenčí.It has been found that the isolation of urethane derivatives as intermediates is not necessary, they can be further converted directly with base or hydrazine. Since the above hydrolyses are rather lengthy (24-48 hours), at which time decomposition and side reactions may already occur, 2,2,2-trichloroethyl chloroformate (I.J) has been proposed for N-demethylation. Browitz, V. Diakiw: J. Heterocyclic Chem. 12, pp. 1,123 (1975); HER. DeGraw, J.H. Lawson, J.L. Crase, H.L. Jonson, M. Ellis, E.T. Uyeno, G.H. Loew, D.S. Berkowitz, J. Med. Chem. 21, p. 415, 1978) and vinyl chloroformate.
Trichlorester má tu přednost, že je reaktivní a že vytvořené urethany se mohou snadno rozkládat aktivovaným zinkovým práškem. Je však nevýhodou, že rozklad urethanů získaných z 14-acyloxymorfinanů je provázen O.—>N acylovou migrací /německá zveřejněná přihláška vynálezu DOS číslo 2 727 805/, což neumožňuje přímou přípravu N-demetylového derivátu.The trichloroester has the advantage that it is reactive and that the formed urethanes can readily decompose with the activated zinc powder. However, it is a disadvantage that the decomposition of urethanes obtained from 14-acyloxymorphinans is accompanied by O-N acyl migration (German Published Application No. 2,727,805), which does not allow the direct preparation of the N-demethyl derivative.
V literatuře byly nalezeny příklady, kdy se vytvářejí zinkové komplexy N-demetylového derivátu /N.P. Peet: J. Pharm. Sci. 69, 1 447, 1980/. Podle údajů v literatuře se za nejdokonalejší N-demetylační činidlo považuje vinylester chlormravenčí kyseliny: americké patentové spisy číslo 3 905 981, 4 141 897, 4 161 597/. Toto činidlo je velice reaktivní pro schopnost vinylové skupiny vázat elektrony, čímž je zaručeno kvantitativní proběhnutí reakce.Examples have been found in the literature where zinc complexes of the N-demethyl derivative / N.P are formed. Peet: J. Pharm. Sci. 69, 1447 (1980)]. According to literature data, chloroformic acid vinyl ester is considered to be the most perfect N-demethylating agent: U.S. Pat. Nos. 3,905,981, 4,141,897, 4,161,597]. This reagent is very reactive for the ability of the vinyl group to bind electrons, thereby ensuring a quantitative reaction.
Jestliže se vinylurethany zpracují ekvivalentním množstvím kyseliny /kyseliny chlorovodíkové, kyseliny bromvodíkové/, dochází к adici, za varu s metanolem se vytvoří sůl sekundárního aminu. Za velmi mírných reakčních podmínek dochází к rozkladu urethanu a tak se může získat sekundární amin ve velmi dobrém výtěžku a o vysoké čistotě.When vinylurethanes are treated with an equivalent amount of acid (hydrochloric acid, hydrobromic acid), addition occurs, boiling with methanol to form the secondary amine salt. Under very mild reaction conditions, the urethane decomposes and the secondary amine can be obtained in very good yield and high purity.
Jestliže urethany, vytvořené z 14-0-acylmorfinanů, se zpracují kyselinou, vytvoří se sůl /hydrochlorid, hydrobromid a pod./ 14-0-acyl-N-demetylované sloučeniny, přičemž v tomto případě nedochází к žádné O--->N acylové migraci.When urethanes formed from 14-O-acylmorphinans are treated with acid, salt / hydrochloride, hydrobromide and the like 14-O-acyl-N-demethylated compound are formed, in which case no O ---> N acyl migration.
Vedle těchto výhod je v.šak třeba uvést, že příprava vinlLettirt cllčrmravinčí kyseliny je obtížná /v důsledku pyrolýzy/, a proto je třeba zkoumat další N-demeiylační způsoby. Pro tento účel byl zvolen difossen, jelikož se ho již úspěšně pouužlo pro N-deemeyyaci propanových alkaloidů. Difo)tgin nebo trCchčoreetyletter hlloreravinčí kyseMny se může snadno připravovat L, Waahkele, A. Synth. £9, 195, cHorací meetlesteru chlormravenčí kyseliny /A. Efraai, I. Feenstein, Goldman: J.However, in addition to these advantages, it should be noted that the preparation of vinilettirt clic acid is difficult (due to pyrolysis) and therefore other N-dimethylation methods need to be investigated. Difossene was chosen for this purpose since it has already been successfully used for the N-deemeylation of propane alkaloids. The diploginine or trichloroethylether of herring acid may be readily prepared by L, Waahkele, A. Synth. £ 9, 195, c. Efraai, I. Feenstein, Goldman, J.
1980/.1980 /.
Ors. Chem. /5, str. 4 059, 1980; K. Kurta, Y. Iwakura: Org.Ors. Chem. / 5, p. 4,059, 1980; K. Kurt, Y. Iwakura: Org.
většině reakcí chová podobně jako fossen /íeden mol dioosgenu jeho teplota varu je 128 °C, jeto tenze je nízká /1,33 kPa/ diossgen ve uvolňuje dva moly focenu/, při teplotě eíst:.nnčti, je novvji velice toxický fossen stále více a více nahrazován dioss^^i^^m. Difossen a fossen reaguj s kyseeiny, meeylová skupina se odštěpuje v případě d^^genu fossen /Н. Babad, A.DMost reactions behaves like fossen / mol íeden dioosgenu its boiling te p is 1 Lot 2 to 8 ° C, is a low tension jeto kA / 1.33 kPa / diossgen in releasing two moles Foceno y /, at net: .nnčti is novvji very toxic fossene is increasingly replaced by dioss ^^ i ^^ m. Difossen and fossen react with the cyanines, the methyl group cleaving off in the case of the fossen / δ gene. Babad, AD
Jelikož se terciárními aminy podobně jako estery hhloreravenčí ve formě meetlchloridu a vytvoří se karbameolchlooid Zzíler: Chem. · Rev. £3, 7 5,.1973/.Since the tertiary amines, like the chloro-esters, are in the form of meetl chloride, a carbameol-chlooid is formed. · Rev. £ 3,757 (1973).
Fossen byl navržen pro N-deirmeyyaci terciárních aminů jako analos reakce podle vonFossen was designed for the N-deirmeyylation of tertiary amines as an analog of the von reaction
Brauna již v roce 1947 /V.A. Rudeko, A.Y. Jakubovich,Braun already in 1947 /V.A. Rudeko, A.Y. Jakubovich,
17,17,
T.Y. NikUrova: J. Gen. Chem. /SSSR/, str. 2 256, 1947, C.A. 42, 4 918e/.YOU. NikUrova: J. Gen. Chem. (USSR), p.2566, 1947, C.A. 42, 4,918e /.
1:1 /Н.1: 1 / Н.
Jelikož fossen může vytvářet s terciárními aminy a 1:2, přčeemž při rozkladu komplexů amin-fossenu Babad, A.D. Zeeler: Chem. Rev. £3, 75 v případě, kdy kommlexy za amin-fosgenového poměru v poměru 1:2 se vytváří terciární am.n , 1973/, je vhodný nadbytek f^ossenu, jelikož je amin v nadbytku se vytváří tetra substituovaná mmoovina.Since fossene can form with tertiary amines and 1: 2, while decomposing the amine-fossene complexes Babad, A.D. Zeeler, Chem. Roar. In the case where the tertiary amine (1: 2) ammonium phosgene ratio is formed in the complexes, an excess of phosphorus is appropriate since the amine is in excess to form a tetra substituted urea.
BanholzerBanholzer
A. Heuuner, W.A. Heuuner, W.
a kol. /britský patentový spis číslo 1 166 798 a 1 167 688 a R. Banhhozer Schnuz: Liebigs Ann. Chem. 2 227, 1975/ jako první popsal N-demeiyУaci alkaloidů s tropanovým skeletem fosgenem a dioosgenem. Zahříváním získaného /izoaace není nutná/ vodou hydrolyzuje na'sekundární aminnClorlydrlt a oxid karbameolchloridU uhličitý.et al. (British Patent Nos. 1,166,798 and 1,167,688 and R. Banhhozer Schnuz: Liebigs Ann. Chem. 2,227, 1975] first described the N-dimethylation of alkaloids with tropane skeleton phosgene and dioosgene. By heating the obtained (isolation) it is not necessary / to hydrolyze to secondary amine chlorlydrate and carbameol chloride carbon dioxide.
Na základě shora uvedeného se jeví jako vhodné přezkoušet N-demeeylaci sloučenin s mmofnnanovým skeletem di-ossí^^i^^m, jelikož pravděpodobně · hydrolýza karbameolcCloridů probíhá za mnohem mírnějších podmínek než urethanů nebo kyanamidů.On the basis of the above, it appears appropriate to test the N-demylation of compounds with a hypophosphite skeleton by dissolution, since the hydrolysis of carbameol chloride is likely to proceed under much milder conditions than urethanes or cyanamides.
Za modelovou sloučeninu se zvolil dihydrokodeion a zjistilo se, že poskytuje očekávaný N-chlorkarbonyl-N-dieeiyl-dihydrokodiinon s diOosgenem v roztoku obsahuúíhím 1,2-dichlor-etan /nebo dicHormetan, chloroform, tetracHorid uHičitý, benzen, toluen/.The dihydrocodeion was chosen as a model compound and was found to provide the expected N-chlorocarbonyl-N-diethyl-dihydrocodiinone with diosgene in a solution containing 1,2-dichloroethane (or dichloromethane, chloroform, carbon tetrachloride, benzene, toluene).
Struktura N-chlčrkarbčnyl-N-dimetyldihydroko>diinčnu byla potvrzena skutečnnotí, že dihydrokodeinon vykazuje podobnou reakci s fossenem, na druhé straně varem cllorkarbčnylové sloučeniny s etanolem se vytváří urethan popsaný v ·.iieeratuře, N-etloxykarbočnl-N-demetyldihydrokodeinon /G. Horváth, P. Kerekes, Gy. Gaai, R. Bognár: Acta Chim. Acad. Sci. Hug.The structure of the N-chlorocarbonyl-N-dimethyldihydrocolinoinine was confirmed by the fact that the dihydrocodeinone exhibits a similar reaction with fossene, on the other hand, by boiling the clorocarbonyl compound with ethanol, the urethane described in the standard, N-Ethyloxycarbone di-N-ethoxycarbone di-N-ethoxycarbone diethyl ether. Horvath, P. Kerekes, Gy. Gaai, R. Bognar: Acta Chim. Acad. Sci. Hug.
82, str. 217, 1974/.82, pp. 217 (1974)].
Bezvodý uhHčitan sodný kataiyzuje vytváření N-cllorkarbčnylovélo derivátu, přieemž poouití bezvodého uhhičiaanu ' sodného je také vhodné pro vázání stop kyseeiny. Pak se N-chlorkarbonylový derivát zahřívá s vodou a může se hydrolyzovat na N-demeiyУdilydrčkodeinon^^γΙ^ι^Ι.Anhydrous sodium carbonate catalyses the formation of an N-chlorocarbonyl derivative, while the use of anhydrous sodium carbonate is also suitable for binding traces of acid. Then, the N-chlorocarbonyl derivative is heated with water and can be hydrolyzed to N-dimethyldilyl codeinone.
Hydroxyskupiny ραιΐΐάβΐίοί z alkoholů nebo z fenolů se mohou acylovat diossgenem a fosgenem v průběhu vytváření chlorovodíkové kyseliny a chlorovodíková kyselina váže terciární amin, čímž je vhodná k chránění derivátů moofinu obsaahuíhíhh hydroxylovou skupinu acyiací.Hydroxy groups ραιΐΐάβΐίοί from alcohols or phenols can be acylated with diossgene and phosgene during the formation of hydrochloric acid and hydrochloric acid binds the tertiary amine, making it suitable for protecting moofin derivatives containing this hydroxyl group by acylation.
Tak například v průběhu hydrolýzy karbamoylchloridu, vytvořeného N-demetylací 3-0-acetyliihydromorfinonu dochází к desacetylaci a vytváří se N-demetyldihydromorfinonchlorhydrát.For example, during the hydrolysis of carbamoyl chloride formed by N-demethylation of 3-O-acetylhydromorphinone, desacetylation occurs and N-demethyldihydromorphinone chlorohydrate is formed.
IAND
Při hydrolýze vodou 6-0-acetyl-N-chlorkarbonyl-N-demetylkodeinu, získaného z 6-0-acelylkodeinu se však vytváří 6-0-acetyl-N-demetylkodein, a proto se v případě morfinu, kodeinu, etylmorfinu, dihydrokodeinu, dihydroetylmorfinu, dihydromořfinu hadrolýza provádí chlorovodíkovou kyselinou o 5% koncentraci. Tak se izoluje N-demetylová sloučenina ve formě jednotného produktu.However, water hydrolysis of 6-O-acetyl-N-chlorocarbonyl-N-demethylcodeine obtained from 6-O-acelyl codeine produces 6-O-acetyl-N-demethylcodeine and therefore, in the case of morphine, codeine, ethylmorphine, dihydrocodeine, dihydroethylmorphine, dihydromorphine hadrolysis performed with 5% hydrochloric acid. Thus the N-demethyl compound is isolated as a uniform product.
Způsob podle vynálezu je vhodný pro odstraňování metylové skupiny z atomu dusíku dihydrokodeinonu, dihydromorfinonu, kodeinu, dihydrokodeinu, morfinu, dihydromorfinu, etylmorfinu, dihydroetylmorfinu, desoxykodeinu-E, dihydrodesoxykodeinu-E, 14-hydroxydihydrokodeinonu, 14-hydroxykodeinonu, 14-hydroxydihydromorfinonu, 3-0-benzylmorfinu a azidomorfinu.The method of the invention is useful for removing a methyl group from a nitrogen atom of dihydrocodeinone, dihydromorphinone, codeine, dihydrocodeine, morphine, dihydromorphine, ethylmorphine, dihydroethylmorphine, desoxycodeine-E, dihydrodesoxycodeine-E, 14-hydroxydihydrocodeinone, 14-hydroxycodeinone, 14-hydroxycodeinone, 14-hydroxycodeinone, O-benzylmorphine and azidomorphine.
Podstata vynálezu je skutečnost, že způsobem, který se dosud naprosto nepoužíval pro obor sloučenin s morfinanovým skeletem se nechávávají reagovat morfinanové alkaloidy obecného vzorce I s fosgenem nebo s difosgenem a převádějí se na N-chlorkarbonyl-N-demetylové sloučeniny obecného vzorce IISUMMARY OF THE INVENTION The present invention is based on the fact that the morphinan alkaloids of the formula I are reacted with phosgene or diphosgene in a manner which has not yet been completely used in the morphinan skeleton compound and are converted to the N-chlorocarbonyl-N-demethyl compounds of the formula II.
/II/ které se převádějí působením vody nebo zředěné minerální kyseliny v dobrém výtěžku a ve vysoké čistotě na N-demetylované deriváty obecného vzorce III.(II) which are converted by treatment with water or dilute mineral acid in good yield and in high purity to the N-demethylated derivatives of the general formula III.
V obecných vzorcích I, II а III mají jednotlivé symboly tento význam:In formulas I, II and III, the symbols have the following meanings:
Z znamená skupinu -CHg-CHg nebo -CH=CH~Z is -CHg-CHg or -CH = CH-
Y znamená atom kyslíku nebo skupinu symbolu Rg a R4, přičemžY is oxygen or a radical Rg, and R 4, wherein
Rg znamená atom vodíku, hydroxylovou skupinu, acyloxyskupinu s 1 až 3 atomy nebo benzoyloxyskupinu a jeho sterická poloha je alfa,R 8 represents a hydrogen atom, a hydroxyl group, an acyloxy group having 1 to 3 atoms or a benzoyloxy group and its steric position is alpha,
R4 znamená atom vodíku, atom halogenu, hydroxylovou skupinu, acyloxyskupinu s 1 až 3 atomy uhlíku, alkylovou skupinu s 1 až 3 atomy uhlíku benzyloxyskupinu nebo azidoskupinu a jeho sterická poloha je beta,R 4 represents a hydrogen atom, halogen atom, hydroxyl group, an acyloxy group having 1 to 3 carbon atoms, alkyl of 1-3 carbon atoms, a benzyloxy group or an azido group and the steric position is beta,
R2 znamená atom vodíku, acyloxyskupinu s 1 až 3 atomy uhlíku nebo benzoyloxyskupinu,R 2 is hydrogen, acyloxy having 1-3 carbon atoms or benzoyloxy,
Rg atom vodíku, alkylovou skupinu s 1 až 5 atomy uhlíku, arylovou skupinu nebo aralkylovou skupinu, acylovou skupinu s 1 až 3 atomy uhlíku nebo benzoylovou skupinu, za podmínky, že v případě, kdyR 8 is hydrogen, C 1 -C 5 alkyl, aryl or aralkyl, C 1 -C 3 acyl or benzoyl, provided that when
Rg znamená atom vodíku, hydroxylovou skupinu, acyloxyskupinu nebo benzoyloxyskupinu, znamenáR 8 represents a hydrogen atom, a hydroxyl group, an acyloxy group or a benzoyloxy group
R4 atom vodíku alkylovou skupinu a v případě, žeR @ 4 is hydrogen or alkyl;
R4 znamená atom vodíku, atom halogenu, hydroxylovou skupinu, alkylovou skupinu, acyloxyskupinu, benzoyloxy skupinu nebo azidoskupinu, znamenáR 4 is hydrogen, halogen, hydroxy, alkyl, acyloxy, benzoyloxy group or an azido group, means
R3 atom vodíku.R 3 is hydrogen.
Sterická poloha skupin symbolu Rg a R4 je - v závislosti na významu skupiny Z - následující: JeštliŽe skupiny symbolu Z je -CHg-CHg- sterická poloha skupiny Rg je axiální a skupiny R4 equatoriální, jestliže Z znamená -CH=CH-, je sterická poloha skupiny Rg kvasi-equatoriální a skupiny R4 kvasi-axiální.The steric position of the Rg and R 4 groups, depending on the meaning of the Z group, is as follows: If the Z group is -CHg-CHg, the steric position of the Rg group is axial and the R 4 group is equatorial if Z is -CH = CH-, the steric position of the Rg group is quasi-equatorial and the R 4 group is quasi-axial.
Důležitým principem způsobu podle vynálezu je poznatek, že se vhodné N-chlorkarbonyl-N-demetylové deriváty mohou hydrolyzovat za mírných a velmi jednoduchých reakčních podmínek,An important principle of the process according to the invention is the finding that suitable N-chlorocarbonyl-N-demethyl derivatives can be hydrolyzed under mild and very simple reaction conditions,
L přičemž nedochází k žádnému rozkladu a k žádným vedlejším reakcím, které jsou nežádoucí, přičemž se při tomto postupu nevytváářjí žádné toxické mmtečné louhy ani toxické odpadní vody.No decomposition and no undesirable side reactions occur, with no toxic leach liquors or toxic effluents.
Pouužtí fosgenu a difosgenu je nejvýhodnnjší se zřetelem na bromkyan a na estery chlormravenčí kyseliny se zřetelem na nebezpečnost reakčních složek, na obtížnost jejich přípravy, na jejich cenu a jejich dostupnost pro provozní měřítko.The use of phosgene and diphosgene is most preferred with respect to cyanogen bromide and chloroformic acid esters with respect to the hazards of the reactants, the difficulty of their preparation, their cost, and their availability on an industrial scale.
Při způsobu podle vynálezu se pouužtí nifusgenu považuje za mnohem výhoddější se zřeteeem na toxický fosgen, přičemž se bere v úvahu, že fosgen, vytvořený v průběhu reakce difosgenu se může bezpečně odstraňovat ze systému vymýváním dusíkem ve vhodné pračce. Způsob podle vynálezu je vhodný pro ekonomickou přípravu N-demetylmoofinanových derivátů důležitých z farmako logického a z terapeutického hlediska ve velkém měřítku.In the process according to the invention, the use of nifusgene is considered to be more advantageous with regard to toxic phosgene, taking into account that the phosgene formed during the diphosgene reaction can be safely removed from the system by flushing with nitrogen in a suitable scrubber. The process according to the invention is suitable for the economical preparation on a large scale of N-demethylmoofinan derivatives important in pharmacological and therapeutic terms.
Vyyniez objasňuuí následnicí příklady praktického provedení, která však vynález nijak neometzjí. Teploty tání se stanovuuí vždy v ^of^rově aparatuře a hodnoty se neupravvuí. Pro chrumatourrf0i v tenké vrstvě se používá folií Merck 5 554 silikagel 60F254* úako tlučníeh prostředí se používá systému benzen : v poměru 8:2; ehloroUrem*'^ ,J' : meano! v poměru 9:1; chlorform : aceton : etylamin v poměru 5:4:1 /ob/te/objee/. Skvrny se identifikují v ultraiaaUvéée světle a pomocí Dragendooffova činidla. PMR spektra se zaznameenávaf v přístroji Bruker W200SY při 200 MHz. Chemický posun se indikuje v /ppm/.The invention is illustrated by the following examples, which are not intended to limit the invention. Melting points were determined in each apparatus and were not adjusted. For chrumatourrf0i thin layer film is used Merck Silica gel 60F254 5554 * u as t l e s h UCN environment, a system b enzen: P in Omer 8: 2; ehloroUrem * '^ , J ': meano! 9: 1; chloroform: acetone: ethylamine in a ratio of 5: 4: 1 (ob / te / volume). The spots are identified under ultra-light and Dragendooff reagent. PMR spectra are recorded in a Bruker W200SY instrument at 200 MHz. The chemical shift is indicated in (ppm).
Pro hmmtová spektra se používá aparatury elektronové ionizace nárazem.Impact electron ionization apparatuses are used for the htm spectra.
typu VG-7035 /GC-MS-DS/ za použití metodytype VG-7035 (GC-MS-DS) using the method
Příklad 1 ml 1,2-dichloretanu, přidá se 1 g /10 mM/ °C se přikape 19,8 g /12 ml, 100 mM/ difosgenu.Example 1 ml of 1,2-dichloroethane, 1 g (10 mM) was added dropwise and 19.8 g (12 ml, 100 mM) of diphosgene was added dropwise.
C aC a
10/ koncentrovaným hydroxidem amonným. Po extrakci se organická fáze promyje solankou a vysuší se síranem % teorie/, teplota tání 150 až 151 °C /etylaceedá/.10) concentrated ammonium hydroxide. After extraction, the organic phase is washed with brine and dried (MgSO4), m.p. 150 DEG-151 DEG C. (ethyl acetate).
N-DDeetytdihydrukodeinonN-DDeetytdihydrucodeinone
Roozuutí se 3g /OmnM·/ nihydrokodeinonu v uhličitanu sodného a za míchání při teplotě 0 Směs se míchá při teplotě 30 °C po dobu 30 minut, pak se nechá ohřát na teplotu místnosti a vaří se za míchání po dobu 10 hodin. Směs se pr-omyje dusíkem a anorganická sůl se ^ΟΟΙ/^^. Roztok, obsahující 1,2-nichlurtthan se promy^ třikrát vždy 20 ml 5% chlorovodíkové kyseliny /ledově chladné/ a pak se organická fáze odpaří ve vakuu. Přidá se 100 ml vody do zbytku a zahřívá se na · vodní lázni po dobu pěti hodin. Pak se ochladí na teplotu pod 10 °< alkalizuje se /na hodnotu pH 9 až chlor formnem /třikrát vždy ·50 ml/ hořečnatým* Výtěžek je 2,33 g /82The mixture is stirred at 30 ° C for 30 minutes, then allowed to warm to room temperature and boiled with stirring for 10 hours. The mixture was purged with nitrogen and the inorganic salt was washed with nitrogen. The solution containing 1,2-nichlurethane was washed three times with 20 ml of 5% hydrochloric acid each (ice cold) and then the organic phase was evaporated in vacuo. Add 100 ml of water to the residue and heat in a water bath for five hours. It is then cooled to below 10 DEG C. (alkalinized) to pH 9 to chlorine (3 times with 50 ml each) of magnesium. Yield: 2.33 g (82%).
PMR /CDC13/: 6,66 dd //-1,2;PMR / CDC1 3 / 6.66 dd // - 1.2;
MS: m/e 285/M*; 23' %/.MS: m / e 285 (MH +); 23%.
2H/; 4,7 s //-5-beta; 1Н/; 3,9 s /OCH3; 3H/2H /; 4.7 s H-5-beta; 1Н /; 3.9 s / OCH3; 3H /
Z 5% roztoku chlorovodíkové kyseliny se může získat 0,4 g /13 %/ dihynrokudtinonu alkalizací /koncentoovaným hydroxidem amonným/ a extrakcí /chlorofylem/.From a 5% hydrochloric acid solution, 0.4 g (13%) of dihynrokudtinone can be obtained by alkalization (with concentrated ammonium hydroxide) and extraction (chlorophyll).
Příklad 2Example 2
N-DDeetytdihydromeuOinonN-DDeetytdihydromeuinone
Rrozpusí se 3,3 g (10 mM/ 3-0-acttyldhhydroeorfinutu v 60 ml 1,2-niehlurttatu, přidá še 1 g /10 ml^/ uhličitanu sodného a za míchání se při teplotě 0°C přikape 19,8 g /12 ml, 100 mM/ dif^^enu. Směs se · míchá při teplotě 0°C po dobu 30 minut, pak se nechá ohřát » na teplotu eíítnouti a vaří se za míchání po dobu 15 hodin. Promyje se dusíkem a anorganická sůl se ^ΟοΙ/^/^ v RíZtok se promy^ třikrát vždy 20 ml 5% chlorovodíkové kyseliny a pak se organická i3.3 g (10 mM) of 3-O-acttyldhhydroeorfinut in 60 ml of 1,2-nehlurttat are dissolved, 1 g (10 ml of sodium carbonate) is added and 19.8 g of sodium carbonate are added dropwise at 0 DEG C. with stirring. The mixture is stirred at 0 ° C for 30 minutes, then allowed to warm to ambient temperature and boiled under stirring for 15 hours. ΟοΙ ^ / ^ / ^ v ^ RíZtok is washed thrice with 20 ml of 5% hydrochloric acid and then the organic and
fáze odpaří ve vakuu. Přidá se 100 ml vody a vaří se po dobu 8 hodin. Ochladí se na teplotu pod 10 °C a chlorhyrát produktu se oddělí v krystalické formě. Odfiltruje se a promyje . se studenou vodou. Výtěžek je 2,15 g /70 % teorie/ chlorhydrátu. Teplota tání získané z chlorhydrátu je 300 až 303 °C. Látka se získá z roztoku v 5% kyselině chlorovodíkové způsobem popsaným v příkladu 1.phase is evaporated in vacuo. Add 100 ml of water and boil for 8 hours. It is cooled to below 10 ° C and the product chlorohydrate is separated in crystalline form. Filter and wash. with cold water. Yield: 2.15 g (70% of theory) of chlorohydrate. The melting point obtained from the chlorohydrate is 300 to 303 ° C. The material was obtained from a solution in 5% hydrochloric acid as described in Example 1.
Příklad 3Example 3
N-DemetylkodeinN-Demethylcodeine
Rozpustí se 3,41 g /10 mM/ 6-0-acetylkodeinu v 80 ml 1,2-dichlorethanu, přidá se g /10 mM/ uhličitanu sodného a za míchání se při teplotě 0°C přikape 19,8 g /12 ml, 100 mM/ difosgenu. Směs se míchá při teplotě 0 °C po dobu 30 minut, pak se nechá ohřát na teplotu místnosti a míchá se a vaří se po dobu 20 hodin. Směs se promyje dusíkem a anorganická sůl se odfiltruje. Zbytek se promyje třikrát vždy 20 ml 5% chlorovodíkové kyseliny a pak se odpaří. Zbytek se vaří s 5% chlorovodíkovou kyselinou po dobu pěti hodin. Ochladí se na teplotu pod 10 °C, produkt se oddělí v krystalické formě, odfiltruje se a promyje se ledovou vodou. Krystalický chlorhydrát se rozpustí ve vodě, alkalizuje se koncentrovaným hydroxidem amonným, extrahuje se .chloroformem a chloroformová fáze se vysuší a odpaří se. Takto získaná báze se překrystaluje z acetonu nebo z etylacetátu. Výtěžek je 2,3 g /80 % teorie/, teplota tání je 185 °C.Dissolve 3.41 g (10 mM) of 6-O-acetyl codeine in 80 ml of 1,2-dichloroethane, add g (10 mM) of sodium carbonate and add dropwise at 0 ° C to 19.8 g / 12 ml. , 100 mM / diphosgene. The mixture was stirred at 0 ° C for 30 minutes, then allowed to warm to room temperature and stirred and boiled for 20 hours. The mixture was purged with nitrogen and the inorganic salt was filtered off. The residue is washed three times with 20 ml of 5% hydrochloric acid each and then evaporated. The residue was boiled with 5% hydrochloric acid for five hours. Cool to below 10 ° C, separate the product in crystalline form, filter and wash with ice water. The crystalline chlorohydrate was dissolved in water, basified with concentrated ammonium hydroxide, extracted with chloroform, and the chloroform phase was dried and evaporated. The base thus obtained is recrystallized from acetone or ethyl acetate. Yield: 2.3 g (80% of theory);
PMR /CDC13/: 6,65 dd/H-1,2; 2H/; 5,7 m /Н-8,; 1H/; 5,3 m /Н-7; 1H/; 4,9 d /Н-5-beta; 1H/; 4,2 m /Н-6-beta; 1Н/; 3,8 s /ОМе; ЗН/.PMR / CDC1 3 / 6.65 dd / H 1.2; 2H /; 5.7 m / N-8 ,; 1H /; 5.3 m / N-7; 1H /; 4.9 d / N-5-beta; 1H /; 4.2 m / N-6-beta; 1Н /; 3.8 s / ОМе; ЗН /.
MS: m/e 285/M+; 100 %/, 215 /50 %/MS: m / e 285 / M < + >; 100% / 215/50% /
Příklad 4Example 4
N-DemetyldihydrokodeinN-Demethyldihydrocodeine
Způsobem podle příkladu 3 se N-demetyluje 3,43 g /10 mM/ 6-0-acetyldihydrokodeinu.Following the procedure of Example 3, N-demethylated 3.43 g (10 mM) of 6-O-acetyldihydrocodeine.
Po kyselé hydrolýze se ochlazením z roztoku neoddělí adiční sůl produktu s chlorovodíkovou kyselinou, proto se směs přímo alkalizuje koncentrovaným hydroxidem amonným, produkt se získá extrakcí chloroformem a překrystaluje se z etanolu. Výtěžek je 1,9 g /66 % teorie/, teplota tání je 194 °C.After acid hydrolysis, the hydrochloride acid addition salt of the product is not separated from the solution by cooling, therefore the mixture is directly basified with concentrated ammonium hydroxide, the product is obtained by extraction with chloroform and recrystallized from ethanol. Yield: 1.9 g (66% of theory);
PMR /CDC13/: 6,7 dd /Н-1,2; 2H/; 4,6 d /Н-5-beta; 1H/; 4,1 m /Н-6-beta; 1H/; 3,8 s/OMe; ЗН/PMR / CDC1 3 / 6,7 dd / Н-1,2; 2H /; 4.6 d / N-5-beta; 1H /; 4.1 m / N-6-beta; 1H /; 3.8 s / OMe; ЗН /
MS: m/e 287 /M+; 100 %/MS: m / e 287 / M < + >; 100% /
Příklad 5Example 5
N-DemetylmorfinN-Demethylmorphine
Rozpustí se 3,7 g /10 mM/ 3,6-di-0-acetylmorfinu ve 100 ml 1,2-dichlorethanu a pak se metylová skupina z atomu dusíku odstraňuje způsobem popsaným v příkladu 3. Po ochlazení roztoku v chlodovodíkové kyselině se hodnota pH upraví na 9 koncentrovaným roztokem hydroxidu amonného. Produkt se oddělí v krystalické formě, odfiltruje se a promyje se studenou vodou. Výtěžek je 2,1 g /77 %/; první generace 1,8 g; z alkalického roztoku za použití systému chloroform - isopropanol /3:1, v/v/ extrakcí se získá 0,3 g druhé generace. Teplota tání je 274 až 277 °C.3.7 g (10 mM) of 3,6-di-O-acetylmorphine are dissolved in 100 ml of 1,2-dichloroethane and then the methyl group is removed from the nitrogen atom as described in Example 3. After cooling the solution in hydrochloric acid, the The pH was adjusted to 9 with concentrated ammonium hydroxide solution. The product is collected in crystalline form, filtered off and washed with cold water. Yield 2.1 g (77%); first generation 1.8 g; from the alkaline solution using chloroform-isopropanol (3: 1, v / v) extraction, 0.3 g of a second generation is obtained. Melting point 274-277 ° C.
PMR /DMSO-dg/í 6,4 dd /Н-1,2; 2Н/; 5,6 m /Н-8; 1H/; 5,2 m /Н-7; 1H/; 4,7 dd /Н-5-beta; 1Н/; 4,1 m /Н-6-beta; 1Н/PMR (DMSO-d6) 6.4 dd / N-1.2; 2Н /; 5.6 m / N-8; 1H /; 5.2 m / N-7; 1H /; 4.7 dd / N-5-beta; 1Н /; 4.1 m / N-6-beta; 1Н /
MS: m/e 271 /M+; 100 %/; 201 /51 %/MS: m / e 271 / M < + >; 100% /; 201/50% /
PříkladěExample
N-DemetyldihydromorfinN-Demethyldihydromorphine
Rozpustí se 3,71 g /10 mM/ 3,6-ii-acetyldihydroooofinu ve 100.ml 1,2-iichlorethanu a N-iernomyluje se způsobem popsaným v příkaadu 5. Výtěžek je 1,65 g /60 %/, teplota tání je 262 až 266 °C.3.71 g (10 mM) of 3,6-ii-acetyldihydroooophin are dissolved in 100 ml of 1,2-dichloroethane and N-iernomylated as described in Example 5. Yield 1.65 g (60%), m.p. mp 262-266 ° C.
PMR /DMSO-di/: 6,5 id /H-1,2; 2H/; 4,2 d /H-5-beta; 1H/; 3,8 m /H-6-beta; 1И/ .PMR (DMSO-d 6): 6.5 id (H-1.2); 2H /; 4.2 d / H-5-beta; 1H /; 3.8 m / H-6-beta; 1И /.
MO: o/e 273 /M* ; 100· %/; 228 /22 %/; 150 /45 %/.MO: o / e 273 / M *; 100 ·% /; 228 (22%); 150 (45%).
Příklad 7Example 7
N-Demotytmerrin-ЗзetyletherN-Demotytmerrin-Zzetylether
Způsobem, popsaným v příkladu 3, se N-iemoeyyuje 3,55 g /10 mM/ 6-0-acetyletyloorfinu. Ochlazením se oddděí chlortyirát produktu, který se odifltruje a promyje .e .ledovou vodou. Z něho se získá báze a překrystaluje se z etarn^lu. Výtěžek je 2,5 g /84 % teorie/, teplota tání je 156 až 157 °C.In the manner described in Example 3, 3.55 g (10 mM) of 6-O-acetylethyloorphine was N -emoeylated. By cooling, the chloro-chlorate of the product is separated, which is filtered off and washed with ice water. The base is recovered and recrystallized from ethanel. Yield is 2.5 g / 84% /, melting point is 156 and 157 ° C.
Píkl ad 8Example 8
N-eemetyldihydroloorfίn-3-etyletterN-methyldihydroloorphine-3-ethyletter
Způsobem, popsaným v příkaadu 4, se N-iemotyluje 3,57 g /10 mM/ 6-0-acetyliityirrttyloorfins. Alkalizací se z roztoku v chlorovodíkové kyselině získá produkt extrakcí a ^^krystaluje se z etyl^acetátu. Výtěžek je 2,32 g /77 % teorie/, teplota tání je 128 až 131 °C.As described in Example 4, 3.57 g (10 mM) of 6-O-acetyliityirrttyloorphines were N-isothylated. By alkalization, the product is extracted from the solution in hydrochloric acid and crystallized from ethyl acetate. Yield is 2.32 g / 77% /, melting point 128-13 1 ° C.
PMR /CDDl3j: 6,6 dd/H-1,2; 2H; 4,5 d /И-5-beta; 1H/; 4,1 m /O-C^-^; 2H/; 3,95 m/H-6-beta; 1Н/; 1,4 t /O-C^-C^; 3HPMR / CDD13 3 : 6.6 dd / H-1.2; 2H; 4.5 d / i-5-beta; 1H /; 4.1 m / OCl2; 2H /; 3.95 m / H-6-beta; 1Н /; 1.4 t / OC2 -C2; 3H
MO: m/e 301 /M+; 100 %/MO: m / e 301 / M < + >; 100% /
Příklad ' 9Example '9
N-Demetyldesoxykodein-EN-Demethyldesoxycodeine-E
Roz^tí se 1,42 g /5 mM/ detrxykodeins-E v 50 ml Přidá se 0,5 g /5 mM/ shiičiaans sodného a do získané suspenze se za míchání a za chlazení uřikaut 6,0 ml /50 mM/ iifosgtns. Po 30 minutách se ustane s mícháním a s chlazením a směs se vaří za míchání po dobu 15 hodin. Po ochlazení se směs promyje dusíkem, anorganická sůl se rdifdtrsjt a organická fáze se promyje dvakrát vždy 20 ml studené 5% chlorovodíkové kyseeiny a slanou vodou. eictlrrtttan se odpaaí ve vakuu, do zbytku se přidá 60 ml vody a směs se zahřívá na vodní lázni po dobu 8 hodin.1.42 g (5 mM) of detrxycodeins-E in 50 ml are added. 0.5 g (5 mM) of sodium sulfite is added and 6.0 ml (50 mM) of diphosphates are added to the suspension while stirring and cooling. . After 30 minutes, stop stirring and cooling and boil the mixture with stirring for 15 hours. After cooling, the mixture was purged with nitrogen, the inorganic salt was decomposed, and the organic phase was washed twice with 20 ml of cold 5% hydrochloric acid each time and brine. Evaporate was removed in vacuo, 60 ml of water was added to the residue, and the mixture was heated on a water bath for 8 hours.
Po . ochlazení se alkalizuje /na hodnotu pH 10 koncentrovaným hydroxidem amonným/ a extrahuje se třikrát vždy 30 ml chloroformu. Po vysušení chloroformu /síannem hořečnatým/ se získá N-dernet;.litsrxykriein-E /0,6 g 60 %/, který je homogenní z hlediska chrroaaoogaaie v tenké vrstvě. i..?'· nevykcrsttaujt/ avšak jestliže se alkoholický roztok ^γβ^ί 48% bromovodíkovou kyselí: o., získá se krystalický hydrrbrroid. Teplota tání je 307 až 310 °C ^/te^ota tání podle ditera.tsry je 311 až 312 °C, R.L. Clark a kol: J. AM. Ctem. Ooc. 35, str. 4963, 1953/ .Mon. cooling was basified (to pH 10 with concentrated ammonium hydroxide) and extracted three times with 30 ml of chloroform each. After drying with chloroform (magnesium sulphate), N-dernetilicrykriein-E (0.6 g 60%) is obtained, which is homogeneous in terms of thin layer chromium-yoga. i ..? '· nevykcrsttaujt / but when an alcoholic solution of ^ ^ ί γβ 48% hydrobromic acidic: o., yielding Cr stalický hyd y yy b rroi d. Having a melting point is from 307 to 3 ° C 10 ^ / ^ TE OTA th n e d i t according to y era.tsr 3 is from 11 to 312 ° C, RL Clark et al: J. AM. Ctem. Ooc. 35, p. 4963, 1953].
Píkl ad 10Example 10
N-eemotyldihyirodtsoxykrdein-EN-eemotyldihyirodtsoxykrdein-E
Jakožto výchozí látky se pobije 1,4 mg /5 mM/ dihy’droitsoxykoieinu~E a postupuje se způsobem popsaným v příkaadu 9. Po extrakci chloroformem sě získá 0,45 g /33 % tmorim/ krystalického N-demoeyУiihyiroitsoxykodeinu-E. Po překrystalování z ttylacttáts je teplota tání 91 až 92 ° /podle literatury je teplota tání 92 až 94 °C; R.L. Clark a kol. J. Adm. Chem. Soc. 75, 4963, 1953/.1.4 mg (5 mM) of dihydroxybenzoic acid E are used as starting materials and the procedure is as described in Example 9. After extraction with chloroform, 0.45 g (33% of fluorine) of crystalline N-demoeylhyiroitoxycodeine-E is obtained. After recrystallization from ethyl acetate, the melting point is 91-92 °; according to the literature, the melting point is 92-94 ° C; R.L. Clark et al. J. Adm. Chem. Soc. 75, 4963 (1953)].
Claims (6)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU842774A HU197750B (en) | 1984-07-17 | 1984-07-17 | Process for n-demethylation of morphine alkaloids |
Publications (2)
Publication Number | Publication Date |
---|---|
CS528085A2 CS528085A2 (en) | 1986-12-18 |
CS251792B2 true CS251792B2 (en) | 1987-08-13 |
Family
ID=10961043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS855280A CS251792B2 (en) | 1984-07-17 | 1985-07-16 | Method of compouns preparation with n-demethylmorphinane skeleton |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0168686B1 (en) |
JP (1) | JPS6193184A (en) |
AT (1) | ATE41933T1 (en) |
BG (1) | BG44029A3 (en) |
CS (1) | CS251792B2 (en) |
DD (1) | DD235639A5 (en) |
DE (1) | DE3569244D1 (en) |
DK (1) | DK322385A (en) |
ES (1) | ES8603716A1 (en) |
FI (1) | FI81583C (en) |
HU (1) | HU197750B (en) |
IL (2) | IL75509A0 (en) |
IN (1) | IN166255B (en) |
NO (1) | NO161915C (en) |
PL (1) | PL254552A1 (en) |
RO (1) | RO91516B (en) |
SU (1) | SU1398776A3 (en) |
YU (1) | YU45264B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2455718T3 (en) * | 2007-12-17 | 2014-04-16 | Mallinckrodt Llc | Procedure and compounds for the production of (+) opiates |
NZ586187A (en) * | 2007-12-17 | 2013-07-26 | Mallinckrodt Llc | Processes for the synthesis of sinomenine derivatives and their intermediate |
WO2010132570A1 (en) * | 2009-05-12 | 2010-11-18 | Board Of Regents The University Of Texas System | Synthesis of morphine and related derivatives |
PL2593095T3 (en) * | 2010-07-16 | 2019-12-31 | Mallinckrodt Llc | (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
BR112014005421A2 (en) | 2011-09-08 | 2017-04-04 | Mallinckrodt Llc | alkaloid production without the isolation of intermediates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA948198A (en) * | 1967-08-04 | 1974-05-28 | Gerhard Walther | Production of cyclic amino compounds |
DE2254298A1 (en) * | 1972-11-06 | 1974-05-16 | Boehringer Sohn Ingelheim | Heteroarylmethyl-normorphines prepn - by alkylation of normorphine etc., antidotes for opiate poisoning |
DE2727805A1 (en) * | 1977-06-21 | 1979-01-04 | Goedecke Ag | METHOD FOR PRODUCING OXYNORMORPHONE |
-
1984
- 1984-07-17 HU HU842774A patent/HU197750B/en not_active IP Right Cessation
-
1985
- 1985-06-13 IL IL75509A patent/IL75509A0/en not_active IP Right Cessation
- 1985-06-14 IN IN476/DEL/85A patent/IN166255B/en unknown
- 1985-06-20 ES ES544385A patent/ES8603716A1/en not_active Expired
- 1985-06-26 AT AT85107895T patent/ATE41933T1/en not_active IP Right Cessation
- 1985-06-26 EP EP85107895A patent/EP0168686B1/en not_active Expired
- 1985-06-26 DE DE8585107895T patent/DE3569244D1/en not_active Expired
- 1985-07-12 DD DD85278546A patent/DD235639A5/en not_active IP Right Cessation
- 1985-07-15 PL PL25455285A patent/PL254552A1/en unknown
- 1985-07-15 FI FI852779A patent/FI81583C/en not_active IP Right Cessation
- 1985-07-15 DK DK322385A patent/DK322385A/en not_active Application Discontinuation
- 1985-07-15 RO RO119568A patent/RO91516B/en unknown
- 1985-07-15 BG BG071084A patent/BG44029A3/en unknown
- 1985-07-16 CS CS855280A patent/CS251792B2/en unknown
- 1985-07-16 JP JP60156846A patent/JPS6193184A/en active Pending
- 1985-07-16 SU SU853923700A patent/SU1398776A3/en active
- 1985-07-16 NO NO852838A patent/NO161915C/en unknown
- 1985-07-17 YU YU1174/85A patent/YU45264B/en unknown
-
1986
- 1986-04-15 IL IL78503A patent/IL78503A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SU1398776A3 (en) | 1988-06-15 |
NO161915B (en) | 1989-07-03 |
BG44029A3 (en) | 1988-09-15 |
FI81583B (en) | 1990-07-31 |
IL78503A (en) | 1990-01-18 |
DD235639A5 (en) | 1986-05-14 |
YU45264B (en) | 1992-05-28 |
IN166255B (en) | 1990-03-31 |
DE3569244D1 (en) | 1989-05-11 |
ATE41933T1 (en) | 1989-04-15 |
FI852779A0 (en) | 1985-07-15 |
ES8603716A1 (en) | 1986-01-16 |
HU197750B (en) | 1989-05-29 |
JPS6193184A (en) | 1986-05-12 |
EP0168686B1 (en) | 1989-04-05 |
YU117485A (en) | 1988-04-30 |
PL254552A1 (en) | 1986-07-15 |
RO91516B (en) | 1987-07-01 |
RO91516A (en) | 1987-06-30 |
CS528085A2 (en) | 1986-12-18 |
EP0168686A1 (en) | 1986-01-22 |
HUT38645A (en) | 1986-06-30 |
IL75509A0 (en) | 1985-10-31 |
DK322385D0 (en) | 1985-07-15 |
FI852779L (en) | 1986-01-18 |
NO161915C (en) | 1989-10-11 |
NO852838L (en) | 1986-01-20 |
FI81583C (en) | 1990-11-12 |
ES544385A0 (en) | 1986-01-16 |
DK322385A (en) | 1986-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1359146B1 (en) | 4-aryl piperidines as opioid receptor binding agents | |
ES2305508T3 (en) | MORFINANO DERIVATIVES REPLACED IN POSITION 14 AND ITS QUATERNARY AMMONIUM SALTS, PREPARATION AND USE PROCEDURE. | |
US20100130512A1 (en) | Fused-ring heterocycle opioids | |
EP2318372B9 (en) | Large substituent, non-phenolic amine opioids | |
ES2201019T3 (en) | NEW PROCEDURE FOR THE PREPARATION OF 11-AMINO-3-CHLORO-6,11-DIHIDRO-5,5-DIOXO-6-METHYL-DIBENZO- (C, F) - (1,2) -TIACEPIN AND ITS APPLICATION TO SYNTHESIS OF TIANEPTINE. | |
CS251792B2 (en) | Method of compouns preparation with n-demethylmorphinane skeleton | |
AU2007267439B2 (en) | Process for the demethylation of oxycodone and related compounds | |
NO167863B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE, CONDENSED, HETEROCYCLIC TETRAHYDROAMINOQINOLINOLS. | |
US4360673A (en) | 5 Phenyl-1,3-alkano-1,2,3,4,4a,9b-hexahydropyrido [4,3-b]indoles | |
JPS62195384A (en) | Novel camptothecin derivative | |
WO1997030049A1 (en) | Process for the preparation of granisetron | |
WO1997019934A1 (en) | Quinoxaline compounds, pharmaceutical preparations containing them and a process for the preparation thereof | |
KR810000583B1 (en) | Method for preparing 4a-aryl-octahydro-1H-2-pyridine | |
AU1402497A (en) | New process for the preparation of morphinans | |
GB2444052A (en) | Processes of preparing morphinan derivatives such as naltrexone and naloxone comprising O- and N-demethylation and reductive alkylation steps | |
Atkinson et al. | Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates | |
WO2008121019A1 (en) | Antihistaminic and antiallergic agent and a method for the production thereof. | |
OHSHIMA et al. | Studies on Aromatic Nitro Compounds. III. Reaction of 2-Nitronaphthalene and 6-Nitroquinoline with Malononitrile in the Presence of Amine | |
CS196323B2 (en) | Method of producing novel derivatives of isoindoline | |
JPS647989B2 (en) | ||
HU210158B (en) | New process for producing n-substituted 6,14-endoethanotetrahydro-thebaine and oripavine derivatives and their salts |